{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T21:35:21Z","timestamp":1773437721139,"version":"3.50.1"},"publisher-location":"Cham","reference-count":79,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319538884","type":"print"},{"value":"9783319538891","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-53889-1_16","type":"book-chapter","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T07:13:29Z","timestamp":1495091609000},"page":"303-319","source":"Crossref","is-referenced-by-count":14,"title":["DNA Modifications and Alzheimer\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Rebecca G.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Lunnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"issue":"3","key":"16_CR1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","volume":"3","author":"R Brookmeyer","year":"2007","unstructured":"Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer\u2019s disease. Alzheimers Dement. 2007;3(3):186\u201391.","journal-title":"Alzheimers Dement"},{"issue":"5580","key":"16_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353\u20136.","journal-title":"Science"},{"issue":"5054","key":"16_CR3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"issue":"4","key":"16_CR4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/0891988705281869","volume":"18","author":"JA Mortimer","year":"2005","unstructured":"Mortimer JA, Borenstein AR, Gosche KM, Snowdon DA. Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression. J Geriatr Psychiatry Neurol. 2005;18(4):218\u201323.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"2","key":"16_CR5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168\u201374.","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"16_CR6","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet. 2009;41(10):1094\u20139.","journal-title":"Nat Genet"},{"issue":"12","key":"16_CR7","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"issue":"11","key":"16_CR8","doi-asserted-by":"crossref","first-page":"e79771","DOI":"10.1371\/journal.pone.0079771","volume":"8","author":"PG Ridge","year":"2013","unstructured":"Ridge PG, Mukherjee S, Crane PK, Kauwe JS, Alzheimer\u2019s Disease Genetics Consortium. Alzheimer\u2019s disease: analyzing the missing heritability. PLoS One. 2013;8(11):e79771.","journal-title":"PLoS One"},{"issue":"Pt 12","key":"16_CR9","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1093\/brain\/awv268","volume":"138","author":"V Escott-Price","year":"2015","unstructured":"Escott-Price V, Sims R, Bannister C, Harold D, Vronskaya M, Majounie E, et al. Common polygenic variation enhances risk prediction for Alzheimer\u2019s disease. Brain J Neurol. 2015;138(Pt 12):3673\u201384.","journal-title":"Brain J Neurol"},{"issue":"16","key":"16_CR10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278(16):1349\u201356.","journal-title":"JAMA"},{"issue":"2","key":"16_CR11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):107\u201316.","journal-title":"N Engl J Med"},{"issue":"2","key":"16_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"6","key":"16_CR13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2009.02.013","volume":"67","author":"LA Profenno","year":"2010","unstructured":"Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzheimer\u2019s disease risk with obesity, diabetes, and related disorders. Biol Psychiatry. 2010;67(6):505\u201312.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"16_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2011.11.017","volume":"88","author":"AM Hall","year":"2012","unstructured":"Hall AM, Roberson ED. Mouse models of Alzheimer\u2019s disease. Brain Res Bull. 2012;88(1):3\u201312.","journal-title":"Brain Res Bull"},{"issue":"6514","key":"16_CR15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 1995;373(6514):523\u20137.","journal-title":"Nature"},{"issue":"5284","key":"16_CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274(5284):99\u2013102.","journal-title":"Science"},{"issue":"24","key":"16_CR17","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1073\/pnas.96.24.14088","volume":"96","author":"ME Calhoun","year":"1999","unstructured":"Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A. 1999;96(24):14088\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"16_CR18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/hmg\/10.12.1317","volume":"10","author":"SL Roberds","year":"2001","unstructured":"Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, et al. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer\u2019s disease therapeutics. Hum Mol Genet. 2001;10(12):1317\u201324.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"16_CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0896-6273(04)00182-5","volume":"42","author":"CA Saura","year":"2004","unstructured":"Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, Shankaranarayana Rao BS, et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron. 2004;42(1):23\u201336.","journal-title":"Neuron"},{"issue":"6618","key":"16_CR20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","volume":"385","author":"RA Black","year":"1997","unstructured":"Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997;385(6618):729\u201333.","journal-title":"Nature"},{"issue":"3","key":"16_CR21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39(3):409\u201321.","journal-title":"Neuron"},{"issue":"Pt 10","key":"16_CR22","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1093\/brain\/awt237","volume":"136","author":"JV Sanchez-Mut","year":"2013","unstructured":"Sanchez-Mut JV, Aso E, Panayotis N, Lott I, Dierssen M, Rabano A, et al. DNA methylation map of mouse and human brain identifies target genes in Alzheimer\u2019s disease. Brain. 2013;136(Pt 10):3018\u201327.","journal-title":"Brain"},{"issue":"3","key":"16_CR23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13760-013-0267-6","volume":"114","author":"L Cong","year":"2014","unstructured":"Cong L, Jia J, Qin W, Ren Y, Sun Y. Genome-wide analysis of DNA methylation in an APP\/PS1 mouse model of Alzheimer\u2019s disease. Acta Neurol Belg. 2014;114(3):195\u2013206.","journal-title":"Acta Neurol Belg"},{"key":"16_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.nbd.2013.09.011","volume":"62","author":"HY Agbemenyah","year":"2014","unstructured":"Agbemenyah HY, Agis-Balboa RC, Burkhardt S, Delalle I, Fischer A. Insulin growth factor binding protein 7 is a novel target to treat dementia. Neurobiol Dis. 2014;62:135\u201343.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"16_CR25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1474-9726.2010.00577.x","volume":"9","author":"RF Thompson","year":"2010","unstructured":"Thompson RF, Atzmon G, Gheorghe C, Liang HQ, Lowes C, Greally JM, et al. Tissue-specific dysregulation of DNA methylation in aging. Aging Cell. 2010;9(4):506\u201318.","journal-title":"Aging Cell"},{"issue":"1","key":"16_CR26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ije\/dyr225","volume":"41","author":"BT Heijmans","year":"2012","unstructured":"Heijmans BT, Mill J. Commentary: The seven plagues of epigenetic epidemiology. Int J Epidemiol. 2012;41(1):74\u20138.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"16_CR27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4161\/epi.23924","volume":"8","author":"J Guintivano","year":"2013","unstructured":"Guintivano J, Aryee MJ, Kaminsky ZA. A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics. 2013;8(3):290\u2013302.","journal-title":"Epigenetics"},{"issue":"5","key":"16_CR28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ageing\/19.5.341","volume":"19","author":"A Burns","year":"1990","unstructured":"Burns A, Jacoby R, Luthert P, Levy R. Cause of death in Alzheimer\u2019s disease. Age Ageing. 1990;19(5):341\u20134.","journal-title":"Age Ageing"},{"issue":"4","key":"16_CR29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ajhg.2011.03.003","volume":"88","author":"LP Breitling","year":"2011","unstructured":"Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H. Tobacco-smoking-related differential DNA methylation: 27 K discovery and replication. Am J Hum Genet. 2011;88(4):450\u20137.","journal-title":"Am J Hum Genet"},{"key":"16_CR30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13148-015-0055-7","volume":"7","author":"A Ruiz-Hernandez","year":"2015","unstructured":"Ruiz-Hernandez A, Kuo CC, Rentero-Garrido P, Tang WY, Redon J, Ordovas JM, et al. Environmental chemicals and DNA methylation in adults: a systematic review of the epidemiologic evidence. Clin Epigenetics. 2015;7:55.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"16_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3945\/an.111.000992","volume":"3","author":"KS Crider","year":"2012","unstructured":"Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate\u2019s role. Adv Nutr. 2012;3(1):21\u201338.","journal-title":"Adv Nutr"},{"issue":"10","key":"16_CR32","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.","journal-title":"Genome Biol"},{"issue":"11","key":"16_CR33","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1080\/15592294.2015.1100786","volume":"10","author":"E Hannon","year":"2015","unstructured":"Hannon E, Lunnon K, Schalkwyk L, Mill J. Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes. Epigenetics. 2015;10(11):1024\u201332.","journal-title":"Epigenetics"},{"issue":"12","key":"16_CR34","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.neurobiolaging.2008.12.005","volume":"31","author":"D Mastroeni","year":"2010","unstructured":"Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. Epigenetic changes in Alzheimer\u2019s disease: decrements in DNA methylation. Neurobiol Aging. 2010;31(12):2025\u201337.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"16_CR35","doi-asserted-by":"crossref","first-page":"e6617","DOI":"10.1371\/journal.pone.0006617","volume":"4","author":"D Mastroeni","year":"2009","unstructured":"Mastroeni D, McKee A, Grover A, Rogers J, Coleman PD. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer\u2019s disease. PLoS One. 2009;4(8):e6617.","journal-title":"PLoS One"},{"issue":"9","key":"16_CR36","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2013.02.021","volume":"34","author":"L Chouliaras","year":"2013","unstructured":"Chouliaras L, Mastroeni D, Delvaux E, Grover A, Kenis G, Hof PR, et al. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer\u2019s disease patients. Neurobiol Aging. 2013;34(9):2091\u20139.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"16_CR37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/nan.12183","volume":"41","author":"T Lashley","year":"2015","unstructured":"Lashley T, Gami P, Valizadeh N, Li A, Revesz T, Balazs R. Alterations in global DNA methylation and hydroxymethylation are not detected in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 2015;41(4):497\u2013506.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"16_CR38","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2013.11.031","volume":"35","author":"N Coppieters","year":"2014","unstructured":"Coppieters N, Dieriks BV, Lill C, Faull RL, Curtis MA, Dragunow M. Global changes in DNA methylation and hydroxymethylation in Alzheimer\u2019s disease human brain. Neurobiol Aging. 2014;35(6):1334\u201344.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"16_CR39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.mad.2013.08.005","volume":"134","author":"MA Bradley-Whitman","year":"2013","unstructured":"Bradley-Whitman MA, Lovell MA. Epigenetic changes in the progression of Alzheimer\u2019s disease. Mech Ageing Dev. 2013;134(10):486\u201395.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"16_CR40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-130506","volume":"37","author":"A Di Francesco","year":"2013","unstructured":"Di Francesco A, Arosio B, Gussago C, Dainese E, Mari D, D'Addario C, et al. Involvement of 5-lipoxygenase in Alzheimer\u2019s disease: a role for DNA methylation. J Alzheimers Dis. 2013;37(1):3\u20138.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"16_CR41","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbi.2011.01.017","volume":"25","author":"V Bollati","year":"2011","unstructured":"Bollati V, Galimberti D, Pergoli L, Dalla Valle E, Barretta F, Cortini F, et al. DNA methylation in repetitive elements and Alzheimer disease. Brain Behav Immun. 2011;25(6):1078\u201383.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"16_CR42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/1533317513505132","volume":"29","author":"HG Hernandez","year":"2014","unstructured":"Hernandez HG, Mahecha MF, Mejia A, Arboleda H, Forero DA. Global long interspersed nuclear element 1 DNA methylation in a Colombian sample of patients with late-onset Alzheimer\u2019s disease. Am J Alzheimers Dis Other Demen. 2014;29(1):50\u20133.","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"6","key":"16_CR43","doi-asserted-by":"crossref","first-page":"e39186","DOI":"10.1371\/journal.pone.0039186","volume":"7","author":"C D'Addario","year":"2012","unstructured":"D'Addario C, Di Francesco A, Arosio B, Gussago C, Dell'Osso B, Bari M, et al. Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease. PLoS One. 2012;7(6):e39186.","journal-title":"PLoS One"},{"issue":"1\u20134","key":"16_CR44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000333799","volume":"10","author":"B Arosio","year":"2012","unstructured":"Arosio B, Bulbarelli A, Bastias Candia S, Lonati E, Mastronardi L, Romualdi P, et al. Pin1 contribution to Alzheimer\u2019s disease: transcriptional and epigenetic mechanisms in patients with late-onset Alzheimer\u2019s disease. Neurodegener Dis. 2012;10(1\u20134):207\u201311.","journal-title":"Neurodegener Dis"},{"key":"16_CR45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuroscience.2012.06.035","volume":"220","author":"TK Furuya","year":"2012","unstructured":"Furuya TK, Silva PN, Payao SL, Bertolucci PH, Rasmussen LT, De Labio RW, et al. Analysis of SNAP25 mRNA expression and promoter DNA methylation in brain areas of Alzheimer\u2019s disease patients. Neuroscience. 2012;220:41\u20136.","journal-title":"Neuroscience"},{"issue":"7","key":"16_CR46","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.neuint.2012.07.014","volume":"61","author":"TK Furuya","year":"2012","unstructured":"Furuya TK, da Silva PN, Payao SL, Rasmussen LT, de Labio RW, Bertolucci PH, et al. SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer\u2019s disease. Neurochem Int. 2012;61(7):973\u20135.","journal-title":"Neurochem Int"},{"issue":"1","key":"16_CR47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3233\/JAD-130428","volume":"38","author":"PN Silva","year":"2014","unstructured":"Silva PN, Furuya TK, Braga IL, Rasmussen LT, Labio RW, Bertolucci PH, et al. Analysis of HSPA8 and HSPA9 mRNA expression and promoter methylation in the brain and blood of Alzheimer\u2019s disease patients. J Alzheimers Dis. 2014;38(1):165\u201370.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"16_CR48","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/hmg\/ddt451","volume":"23","author":"A Iwata","year":"2014","unstructured":"Iwata A, Nagata K, Hatsuta H, Takuma H, Bundo M, Iwamoto K, et al. Altered CpG methylation in sporadic Alzheimer\u2019s disease is associated with APP and MAPT dysregulation. Hum Mol Genet. 2014;23(3):648\u201356.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"16_CR49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/01677063.2010.503978","volume":"24","author":"J Brohede","year":"2010","unstructured":"Brohede J, Rinde M, Winblad B, Graff C. A DNA methylation study of the amyloid precursor protein gene in several brain regions from patients with familial Alzheimer disease. J Neurogenet. 2010;24(4):179\u201381.","journal-title":"J Neurogenet"},{"issue":"7","key":"16_CR50","doi-asserted-by":"crossref","first-page":"e2698","DOI":"10.1371\/journal.pone.0002698","volume":"3","author":"SC Wang","year":"2008","unstructured":"Wang SC, Oelze B, Schumacher A. Age-specific epigenetic drift in late-onset Alzheimer\u2019s disease. PLoS One. 2008;3(7):e2698.","journal-title":"PLoS One"},{"issue":"8","key":"16_CR51","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/NEN.0b013e3181af2e46","volume":"68","author":"M Barrachina","year":"2009","unstructured":"Barrachina M, Ferrer I. DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J Neuropathol Exp Neurol. 2009;68(8):880\u201391.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"16_CR52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-2012-121192","volume":"33","author":"PN Silva","year":"2013","unstructured":"Silva PN, Furuya TK, Sampaio Braga I, Rasmussen LT, de Labio RW, Bertolucci PH, et al. CNP and DPYSL2 mRNA expression and promoter methylation levels in brain of Alzheimer\u2019s disease patients. J Alzheimers Dis. 2013;33(2):349\u201355.","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"16_CR53","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/jnen\/63.10.1080","volume":"63","author":"E Sontag","year":"2004","unstructured":"Sontag E, Hladik C, Montgomery L, Luangpirom A, Mudrak I, Ogris E, et al. Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J Neuropathol Exp Neurol. 2004;63(10):1080\u201391.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"16_CR54","doi-asserted-by":"crossref","first-page":"e895","DOI":"10.1371\/journal.pone.0000895","volume":"2","author":"KD Siegmund","year":"2007","unstructured":"Siegmund KD, Connor CM, Campan M, Long TI, Weisenberger DJ, Biniszkiewicz D, et al. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS One. 2007;2(9):e895.","journal-title":"PLoS One"},{"key":"16_CR55","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/tp.2012.55","volume":"2","author":"JS Rao","year":"2012","unstructured":"Rao JS, Keleshian VL, Klein S, Rapoport SI. Epigenetic modifications in frontal cortex from Alzheimer\u2019s disease and bipolar disorder patients. Transl Psychiatry. 2012;2:e132.","journal-title":"Transl Psychiatry"},{"issue":"3","key":"16_CR56","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3233\/JAD-2012-111223","volume":"29","author":"KM Bakulski","year":"2012","unstructured":"Bakulski KM, Dolinoy DC, Sartor MA, Paulson HL, Konen JR, Lieberman AP, et al. Genome-wide DNA methylation differences between late-onset Alzheimer\u2019s disease and cognitively normal controls in human frontal cortex. J Alzheimers Dis. 2012;29(3):571\u201388.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"16_CR57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hipo.22245","volume":"24","author":"JV Sanchez-Mut","year":"2014","unstructured":"Sanchez-Mut JV, Aso E, Heyn H, Matsuda T, Bock C, Ferrer I, et al. Promoter hypermethylation of the phosphatase DUSP22 mediates PKA-dependent TAU phosphorylation and CREB activation in Alzheimer\u2019s disease. Hippocampus. 2014;24(4):363\u20138.","journal-title":"Hippocampus"},{"issue":"9","key":"16_CR58","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/nn.3786","volume":"17","author":"PL De Jager","year":"2014","unstructured":"De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, et al. Alzheimer\u2019s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014;17(9):1156\u201363.","journal-title":"Nat Neurosci"},{"issue":"9","key":"16_CR59","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/nn.3782","volume":"17","author":"K Lunnon","year":"2014","unstructured":"Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer\u2019s disease. Nat Neurosci. 2014;17(9):1164\u201370.","journal-title":"Nat Neurosci"},{"issue":"9","key":"16_CR60","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nn.3792","volume":"17","author":"J Lord","year":"2014","unstructured":"Lord J, Cruchaga C. The epigenetic landscape of Alzheimer\u2019s disease. Nat Neurosci. 2014;17(9):1138\u201340.","journal-title":"Nat Neurosci"},{"key":"16_CR61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.nepig.2016.05.001","volume":"6","author":"AR Smith","year":"2016","unstructured":"Smith AR, Mill J, Smith RG, Lunnon K. Elucidating novel dysfunctional pathways in Alzheimer\u2019s disease by integrating loci identified in genetic and epigenetic studies. Neuroepigenetics. 2016;6:32\u201350.","journal-title":"Neuroepigenetics"},{"issue":"6","key":"16_CR62","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/acn3.201","volume":"2","author":"LB Chibnik","year":"2015","unstructured":"Chibnik LB, Yu L, Eaton ML, Srivastava G, Schneider JA, Kellis M, et al. Alzheimer\u2019s loci: epigenetic associations and interaction with genetic factors. Ann Clin Transl Neurol. 2015;2(6):636\u201347.","journal-title":"Ann Clin Transl Neurol"},{"key":"16_CR63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neurobiolaging.2016.07.008","volume":"47","author":"AR Smith","year":"2016","unstructured":"Smith AR, Smith RG, Condliffe D, Hannon E, Schalkwyk L, Mill J, et al. Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer\u2019s disease brain. Neurobiol Aging. 2016;47:35\u201340.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"16_CR65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13073-015-0258-8","volume":"8","author":"CT Watson","year":"2016","unstructured":"Watson CT, Roussos P, Garg P, Ho DJ, Azam N, Katsel PL, et al. Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer\u2019s disease. Genome Med. 2016;8(1):5.","journal-title":"Genome Med"},{"issue":"11","key":"16_CR66","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/nbt.2398","volume":"30","author":"CX Song","year":"2012","unstructured":"Song CX, Yi C, He C. Mapping recently identified nucleotide variants in the genome and transcriptome. Nat Biotechnol. 2012;30(11):1107\u201316.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"16_CR67","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nbt.1732","volume":"29","author":"CX Song","year":"2011","unstructured":"Song CX, Szulwach KE, Fu Y, Dai Q, Yi C, Li X, et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol. 2011;29(1):68\u201372.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"16_CR68","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1101\/gr.126417.111","volume":"22","author":"CE Nestor","year":"2012","unstructured":"Nestor CE, Ottaviano R, Reddington J, Sproul D, Reinhardt D, Dunican D, et al. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res. 2012;22(3):467\u201377.","journal-title":"Genome Res"},{"issue":"10","key":"16_CR69","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nsmb.2372","volume":"19","author":"T Khare","year":"2012","unstructured":"Khare T, Pai S, Koncevicius K, Pal M, Kriukiene E, Liutkeviciute Z, et al. 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary. Nat Struct Mol Biol. 2012;19(10):1037\u201343.","journal-title":"Nat Struct Mol Biol"},{"issue":"8","key":"16_CR70","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.neurobiolaging.2014.02.002","volume":"35","author":"D Condliffe","year":"2014","unstructured":"Condliffe D, Wong A, Troakes C, Proitsi P, Patel Y, Chouliaras L, et al. Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer\u2019s disease brain. Neurobiol Aging. 2014;35(8):1850\u20134.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"16_CR71","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2144\/000113403","volume":"48","author":"C Nestor","year":"2010","unstructured":"Nestor C, Ruzov A, Meehan R, Dunican D. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques. 2010;48(4):317\u20139.","journal-title":"Biotechniques"},{"key":"16_CR72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ymeth.2014.08.009","volume":"72","author":"SK Stewart","year":"2015","unstructured":"Stewart SK, Morris TJ, Guilhamon P, Bulstrode H, Bachman M, Balasubramanian S, et al. oxBS-450 K: a method for analysing hydroxymethylation using 450 K BeadChips. Methods. 2015;72:9\u201315.","journal-title":"Methods"},{"key":"16_CR73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13059-016-0871-x","volume":"17","author":"K Lunnon","year":"2016","unstructured":"Lunnon K, Hannon E, Smith RG, Dempster E, Wong C, Burrage J, et al. Variation in 5-hydroxymethylcytosine across human cortex and cerebellum. Genome Biol. 2016;17:27.","journal-title":"Genome Biol"},{"issue":"2","key":"16_CR74","doi-asserted-by":"crossref","first-page":"e0118202","DOI":"10.1371\/journal.pone.0118202","volume":"10","author":"SF Field","year":"2015","unstructured":"Field SF, Beraldi D, Bachman M, Stewart SK, Beck S, Balasubramanian S. Accurate measurement of 5-methylcytosine and 5-hydroxymethylcytosine in human cerebellum DNA by oxidative bisulfite on an array (OxBS-array). PLoS One. 2015;10(2):e0118202.","journal-title":"PLoS One"},{"issue":"2","key":"16_CR75","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/NMM:5:2:147","volume":"5","author":"M Manczak","year":"2004","unstructured":"Manczak M, Park BS, Jung Y, Reddy PH. Differential expression of oxidative phosphorylation genes in patients with Alzheimer\u2019s disease: implications for early mitochondrial dysfunction and oxidative damage. Neruomol Med. 2004;5(2):147\u201362.","journal-title":"Neruomol Med"},{"issue":"3","key":"16_CR76","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3233\/JAD-2012-111592","volume":"30","author":"K Lunnon","year":"2012","unstructured":"Lunnon K, Ibrahim Z, Proitsi P, Lourdusamy A, Newhouse S, Sattlecker M, et al. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer\u2019s disease blood. J Alzheimers Dis. 2012;30(3):685\u2013710.","journal-title":"J Alzheimers Dis"},{"issue":"5806","key":"16_CR77","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/290457a0","volume":"290","author":"S Anderson","year":"1981","unstructured":"Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290(5806):457\u201365.","journal-title":"Nature"},{"issue":"6","key":"16_CR78","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2217\/epi.14.50","volume":"6","author":"M Devall","year":"2014","unstructured":"Devall M, Mill J, Lunnon K. The mitochondrial epigenome: a role in Alzheimer\u2019s disease? Epigenomics. 2014;6(6):665\u201375.","journal-title":"Epigenomics"},{"key":"16_CR79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neulet.2016.02.013","volume":"625","author":"M Devall","year":"2016","unstructured":"Devall M, Roubroeks J, Mill J, Weedon M, Lunnon K. Epigenetic regulation of mitochondrial function in neurodegenerative disease: new insights from advances in genomic technologies. Neurosci Lett. 2016;625:47\u201355.","journal-title":"Neurosci Lett"},{"issue":"6213","key":"16_CR80","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(6213):1258096.","journal-title":"Science"}],"container-title":["Advances in Experimental Medicine and Biology","Neuroepigenomics in Aging and Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-53889-1_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T20:07:46Z","timestamp":1569355666000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-53889-1_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319538884","9783319538891"],"references-count":79,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-53889-1_16","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}